Brief: Alpha Cognition Announce Data From Pre-Clinical Study Of Alpha-1062 For Traumatic Brain Injury
06/12/2021 14:33
Dec 6 (Reuters) - Alpha Cognition Inc ACOG.V :
* ALPHA COGNITION ANNOUNCE DATA FROM PRE-CLINICAL STUDY OF
ALPHA-1062 FOR TRAUMATIC BRAIN INJURY
* ALPHA COGNITION - ALPHA-1062 ADMINISTRATION SIGNIFICANTLY,
ACUTELY REDUCED EXTENT OF FUNCTIONAL DEFICIT & IMPROVED
FUNCTIONAL RECOVERY OF TBI ANIMALS
Source text for Eikon: ID:nBw3PwTcga
Further company coverage: ACOG.V
((reuters.briefs@thomsonreuters.com;))
Recent news on Alpha Cognition
See all newsBrief: Alpha Cognition Announces Pricing Of $50 Million Upsized Public Offering And Nasdaq Listing
Brief: Alpha Cognition Inc - Files Registration Statement For $25 Million Offering
Brief: Alpha Cognition Announces Completion Of $4.545 Million Convertible Note And Warrants Bridge Financing
Brief: Alpha Cognition Says On Track To Secure Financing For Continued Growth
Brief: Alpha Cognition Inc Says Applied To List Common Shares On Nasdaq Under Trading Symbol “Acog”